Xiao-Qiang Li

Xiao-Qiang Li


Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 December 2022 in Acta Biomaterialia
Verified
Journal Article
Closed access
NHNan Hu
Nan Hu
ZCZhengwei Cai
Zhengwei Cai
XJXudong Jiang
Xudong Jiang
CWChuang Wang
Chuang Wang
TTTao Tang
Tao Tang
Wenguo CuiWenguo Cui
Wenguo Cui

29 June 2018 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
PDF file
LSLi-Li Sun
Li-Li Sun
WLWen-Dong Li
Wen-Dong Li
FLFeng‐Rui Lei
Feng‐Rui Lei
XLXiao-Qiang Li
Xiao-Qiang Li
MicroRNAs (miRNAs) are small non‐coding RNAs that regulate gene expression at a post‐transcriptional level via either the degradation or translational repression of a target mRNA. They play an irreplaceable role in angiogenesis by regulating the proliferation, differentiation, apoptosis, migration and tube formation of angiogenesis‐related cells, which are indispensable for multitudinous physiological and pathological processes, especially for the occurrence and development of vascular diseases. Imbalance between the regulation of miRNAs and angiogenesis may cause many diseases such as cancer, cardiovascular disease, aneurysm, Kawasaki disease, aortic dissection, phlebothrombosis and diabetic microvascular complication. Therefore, it is important to explore the essential role of miRNAs in angiogenesis, which might help to uncover new and effective therapeutic strategies for vascular diseases. This review focuses on the interactions between miRNAs and angiogenesis, and miRNA‐based biomarkers in the diagnosis, treatment and prognosis of angiogenesis‐related diseases, providing an update on the understanding of the clinical value of miRNAs in targeting angiogenesis.

1 September 2018 in European Journal of Cell Biology
Verified
Journal Article
Closed access
HLhong lei
hong lei
XDXiaolong Du
Xiaolong Du
WLWendong Li
Wendong Li
YMYoujun Mao
Youjun Mao
LSLili Sun
Lili Sun
XLXiao-Qiang Li
Xiao-Qiang Li

1 September 2018 in Stem Cells
Verified
Journal Article
Open access
PDF file
WLWen-Dong Li
Wen-Dong Li
DZDong-Ming Zhou
Dong-Ming Zhou
LSLi-Li Sun
Li-Li Sun
LXLun Xiao
Lun Xiao
ZLZhao Liu
Zhao Liu
XLXiao-Qiang Li
Xiao-Qiang Li
Efficient recruitment and angiogenesis of endothelial progenitor cells (EPCs) are critical during a thrombus event. However, the details of EPC recruitment and the regulation of angiogenesis have not been fully determined. The aim of this study was to determine the role of the long noncoding (lnc)RNA Wilms tumor 1 associated protein pseudogene 1 (WTAPP1) in regulation of the migration and angiogenesis of EPCs. EPCs were isolated from human peripheral blood and characterized by flow cytometry, after which lentivirus-mediated lncRNA WTAPP1 overexpression and knockdown were performed. Scratch assay, Transwell assay, and in vitro and in vivo tube formation assays were performed to measure cell migration, invasion, and angiogenic abilities, respectively. Moreover, a microarray screen, bioinformatic prediction, and quantitative PCR and Western blot of miRNAs interacting with lncRNA WTAPP1 were conducted. Western blot was carried out to elucidate the relationship among WTAPP1, miR-3120-5P, and MMP-1 in the autophagy pathway. WTAPP1 positively regulated migration, invasion, and in vitro and in vivo tube formation in EPCs by increasing MMP-1 expression and activating PI3K/Akt/mTOR signaling. Furthermore, WTAPP1 contains a putative miR-3120-5P binding site. Suppression of WTAPP1 by miR-3120-5P decreased the level of MMP-1. In addition, we demonstrated that suppression of the autophagy pathway is involved in the effects of WTAPP1 on EPC migration and angiogenesis. The lncRNA WTAPP1, a molecular decoy for miR-3120-5p, regulates MMP-1 expression via the PI3K/Akt and autophagy pathways, thereby mediating cell migration and angiogenesis in EPCs. Acting as a potential therapeutic target, the lncRNA WTAPP1 may play an important role in the pathogenesis of DVT. Stem Cells 2018;36:1863–12

1 August 2016 in Vascular Pharmacology
Verified
Journal Article
Closed access
WLWen-Dong Li
Wen-Dong Li
XLXiao-Qiang Li
Xiao-Qiang Li

21 March 2017 in International Journal of Molecular Medicine
Verified
Journal Article
Open access
PDF file
WLWen-Dong Li
Wen-Dong Li
NLNeng-Ping Li
Neng-Ping Li
DSDan-Dan Song
Dan-Dan Song
JRJian-Jie Rong
Jian-Jie Rong
AQAi-Min Qian
Ai-Min Qian
XLXiao-Qiang Li
Xiao-Qiang Li
The aim of the present study was to investigate the effect of metformin on endothelial progenitor cell (EPC) migration and to explore the possible mechanisms. EPCs were treated with metformin, and the migration of EPCs was evaluated by wound healing and Matrigel invasion assays. We also examined the expression levels of of MMP-2 and MMP-9 in EPCs with or without metformin treatment via RT-PCR and western blot analysis, and activities of MMP-2 and MMP-9 in EPCs under different conditions was examined by zymography. Moreover, we also assessed the AMPK/mTOR/autophagy pathway to explore the possible mechanisms. Metformin treatment significantly downregulated matrix metalloproteinase-2 (MMP-2) and MMP-9 expression, and subsequently decreased the migration of EPCs. Increased levels of phosphorylated (p)-AMPK and LC3II expression, as well as decreased levels of p-mTOR and p62 contributed to this phenomenon. The AMPK inhibitor compound C reversed the effect exerted by metformin. In conclusion, our results showed that metformin inhibited the migration of EPCs by decreasing MMP-2 and MMP-9. The AMPK/mTOR/autophagy pathway was demonstrated to be involved in the regulatory mechanisms.